Lawmakers calls for transparent drug pricing negotiation

The current positive list system stipulates a strict screening process of new drugs eligible for national health insurance reimbursement. It aims to encourage pharmaceutical producers to come up with ways to offer effective drugs at cheaper prices.

To this end, the National Health Insurance Corporation decides which new drugs are to be put on the positive list and how much they will cost thr...